Posts in category: Uncategorized

Rogue clinics selling stem cell therapies are popping up everywhere. There are thousands of them around the world, and they claim to be able to cure everything from autism to cerebral palsy.

In the to and fro of daily life, an accidental knock to the breast can hurt for a moment. But in the push and shove on the sporting field—such as the upcoming 2023 FIFA Women’s World Cup—a blow to the breast can cause breast pain, swelling and bruising.

A recent study from the lab of the University of Kentucky’s Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., centers around the idea that various anti-inflammatory drugs could be effective treatments for Alzheimer’s disease (AD).

Research led by the People’s Hospital of Zhengzhou University, China, has found a connection between gut microbiota and distal symmetric polyneuropathy. In a paper, “Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes,” published in Cell Metabolism, the team finds a potential causal role of the gut microbiota in distal symmetric polyneuropathy symptoms.

In a large-scale study, research teams from the University of Würzburg and the Ludwigshafen Municipal Hospital have investigated whether risk of stroke recurrences can be reduced by a structured outpatient follow-up care program.

McMaster researchers have uncovered a fast and effective way to detect cancer stem cells before the disease recurs in adults who previously underwent treatment.

Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, yet remained high for those living at home, according to a new study led by UC San Francisco.

Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the pancreatic cancer vaccine GVAX, the immune checkpoint therapy nivolumab and urelemab, an anti-CD137 agonist antibody treatment, is safe, increases the amount of cancer-killing immune system T cells in the tumors and appears effective when given two weeks prior to cancer-removal surgery, according to new research directed by Johns Hopkins investigators.

Since the concept of “gut-joint” axis was proposed, increasing evidence has shown that the imbalance of gut microbiota may play a key role in the occurrence and development of rheumatoid arthritis (RA).

By BUUMBA CHIMBULU

STANDARD Chartered bank is set to sell its shareholding in some of its subsidiaries in Sub-Saharan African countries to Nigeria’s Access Bank following the agreement which has been signed by the two entities.

The shareholding to be affected are in its subsidiaries in Angola, Cameroon, The Gambia, and Sierra Leone, as well as its Consumer, Private & Business Banking business in Tanzania.

The bank, in a statement, however indicated that each transaction remained subject to the approval of the respective local regulators and the banking regulator in Nigeria.

The announcement was made on Friday at Standard Chartered’s Headquarters in London in the presence of senior representatives from both banks.

Signed by, Sunil Kaushal, Regional Chief Executive Officer, Africa & Middle East, Standard Chartered and, Roosevelt Ogbonna, Group Managing Director, Access Bank Plc.

“The agreement with Access for the sale of the bank’s business in Sub-Saharan Africa is in line with Standard Chartered’s global strategy, aimed at achieving operational efficiencies, reducing complexity, and driving scale,” according to the statement.

Commenting on the agreement, Mr Kaushal said this strategic decision allowed the bank to redirect resources within the AME region to other areas with significant growth potential, ultimately enabling it to better support its clients.

He said the bank looked forward to working closely with Access Bank’s team over the coming months to achieve a successful conclusion to this transaction while safeguarding the interests of its valued clients and prioritising employees.

“Following on the announcement we made in April last year, the project is now substantially completed with the announcement for the sale of the 5 markets and the furtherance of a partnership with Access Bank,” Mr Kaushal said.

Access Bank will provide a full range of banking services and continuity for key stakeholders including employees and clients of Standard Chartered’s businesses across the five aforementioned countries. Access Bank and Standard Chartered will work closely together in the coming months to ensure a seamless transition, with the transaction expected to be completed over the next 12 months.

Roosevelt Ogbonna, Group Managing Director, Access Bank Plc, was pleased to sign the agreement.

Mr Ogbonna expressed his bank’s appreciation for being selected as the preferred partner to Standard Chartered through the transaction, in which it was exiting four African markets and refocusing in one.

“At Access Bank, we are committed to reshaping the global perception of Africa and African businesses, even as we continue to build toward our vision to be the World’s Most Respected African Bank.

“Our 5-year growth plan will see us build a world-class class payments gateway leveraging the power of technology and a robust network of relationships across our operating countries,” he said.

He explained that this would be supported by a dynamic ecosystem of local and international partnerships, enabling us to serve global payments and remittances efficiently.